Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd Financial Flexibility Index

Latest as of September 2025: 0.23x

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd financial flexibility index. Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd (688505) has a Financial Flexibility Index of 0.23x as of September 2025. Free cash flow of CN¥47.42 Million (operating CF CN¥43.77 Million minus capex CN¥3.65 Million) represents 0% of total liabilities (CN¥207.05 Million). See Shanghai Fudan-Zhangjiang Bio-Pharmaceut free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.

Financial Flexibility Index

0.23x
Free Cash Flow / Total Liabilities

Free Cash Flow

CN¥47.42 Million
Operating CF − Capex

Total Liabilities

CN¥207.05 Million
CNY

Capital Expenditures

CN¥3.65 Million
CNY

Financial Flexibility Index of Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd (2006–2025)

Financial flexibility index of Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd from 2006 to 2025. Historical Financial Flexibility Index trend for Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd across 20 annual periods. Check Shanghai Fudan-Zhangjiang Bio-Pharmaceut cash flow quality index to evaluate the quality of earnings relative to operating cash generation.

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd Financial Flexibility Index by Year (2006–2025)

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd financial flexibility index by year from 2006 to 2025. Year-by-year free cash flow to debt coverage for Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd. For the full cash flow conversion analysis, see Shanghai Fudan-Zhangjiang Bio-Pharmaceut cash flow conversion.

Year Flexibility Index Free Cash Flow (CNY) Operating CF Total Liabilities YoY Change
2025 0.63x CN¥173.76 Million CN¥141.40 Million CN¥273.93 Million ▲ +539.4%
2024 0.10x CN¥27.90 Million CN¥-14.77 Million CN¥281.23 Million ▼ -69.8%
2023 0.33x CN¥169.98 Million CN¥71.02 Million CN¥518.12 Million ▼ -6.1%
2022 0.35x CN¥252.57 Million CN¥165.27 Million CN¥722.99 Million ▼ -46.9%
2021 0.66x CN¥389.02 Million CN¥268.90 Million CN¥591.58 Million ▲ +108.3%
2020 0.32x CN¥155.41 Million CN¥113.00 Million CN¥492.21 Million ▼ -35.6%
2019 0.49x CN¥309.62 Million CN¥269.23 Million CN¥631.68 Million ▲ +7.9%
2018 0.45x CN¥211.73 Million CN¥173.94 Million CN¥466.08 Million ▲ +10.7%
2017 0.41x CN¥103.65 Million CN¥42.71 Million CN¥252.65 Million ▼ -45.8%
2016 0.76x CN¥187.40 Million CN¥140.57 Million CN¥247.70 Million ▲ +41.5%
2015 0.53x CN¥136.04 Million CN¥96.30 Million CN¥254.43 Million ▼ -40.6%
2014 0.90x CN¥133.26 Million CN¥88.36 Million CN¥148.06 Million ▲ +12.4%
2013 0.80x CN¥146.82 Million CN¥89.44 Million CN¥183.29 Million ▼ -1.3%
2012 0.81x CN¥224.88 Million CN¥110.19 Million CN¥277.18 Million ▲ +55.1%
2011 0.52x CN¥82.58 Million CN¥49.59 Million CN¥157.81 Million ▲ +2984.2%
2010 0.02x CN¥2.30 Million CN¥-7.11 Million CN¥135.45 Million ▼ -96.5%
2009 0.49x CN¥63.54 Million CN¥7.72 Million CN¥130.46 Million ▲ +410.0%
2008 -0.16x CN¥-12.97 Million CN¥-15.89 Million CN¥82.57 Million ▲ +14.5%
2007 -0.18x CN¥-10.91 Million CN¥-17.18 Million CN¥59.34 Million ▼ -75.7%
2006 -0.10x CN¥-4.53 Million CN¥-21.40 Million CN¥43.32 Million —
Financial Flexibility Index = (Operating CF − Capex) / Total Liabilities = Free Cash Flow / Total Liabilities